Keryx Biopharma (KERX) Files $100M Mixed Securities Shelf
- Market Wrap: Pending Sales Slide in June; Herbalife Hit on Q2 Results, Outlook; Netflix...Yada, Yada, Yada...Seinfeld?
- After-Hours Stock Movers 7/28: (CGNX) (HLS) (AMKR) Higher; (KBIO) (HLF) (TTS) Lower (more...)
- Herbalife (HLF) Misses Q2 EPS by 2c; Guides Q3 EPS Below Views
- Dollar Tree (DLTR) to Acquire Family Dollar (FDO) for $74.50/Share
- Darden Restaurants (DRI) Chairman, CEO Otis to Step Down
Keryx Biopharma (Nasdaq: KERX) filed for a $100 million mixed securities shelf.
You May Also Be Interested In
- Keryx Biopharma (KERX) Reports Zerenex Met Primary Endpoint in Phase 3
- Mines Management (MGN) Plans 4,000 Units Offering
- Ceragon Networks Ltd (CRNT) Plans Ordinary Share Offering
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!